Trial Outcomes & Findings for Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video (NCT NCT04476654)
NCT ID: NCT04476654
Last Updated: 2024-10-22
Results Overview
Our primary outcome will be for participants to receive genetic testing and counseling.Investigators will be able to see if participant has scheduled a genetic testing appointment within the VCU Health appointment system.
COMPLETED
NA
57 participants
3 months
2024-10-22
Participant Flow
Trained clinical coordinators recruited participants, administered surveys and abstracted information on genetic counseling and testing from participant medical records
The clinical research assistants consented interested patients . Following consent, women completed a baseline survey. Next, women were randomized into study arms.
Participant milestones
| Measure |
Fact Sheet Arm
Komen print materials about genetic counseling and testing will be given to women.
|
YouTube Video Arm
Participants in this arm will receive the culturally tailored video either via a Youtube link or a DVD.
YouTube Video Arm: Participants (n=25) will watch a 20 minute YouTube video that will describe the genetic counseling and testing process and risk/benefit information in a culturally relevant format. Participants will complete pre and post assessments. After the session, participants interested in pursuing genetic counseling and testing services will be referred to a patient navigator who will navigate participants to identified no cost or low cost services.
|
|---|---|---|
|
Overall Study
STARTED
|
29
|
28
|
|
Overall Study
COMPLETED
|
26
|
26
|
|
Overall Study
NOT COMPLETED
|
3
|
2
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video
Baseline characteristics by cohort
| Measure |
Fact Sheet Arm
n=29 Participants
Komen print materials about genetic counseling and testing will be given to women.
|
YouTube Video Arm
n=28 Participants
Participants in this arm will receive the culturally tailored video either via a Youtube link or a DVD.
YouTube Video Arm: Participants (n=25) will watch a 20 minute YouTube video that will describe the genetic counseling and testing process and risk/benefit information in a culturally relevant format. Participants will complete pre and post assessments. After the session, participants interested in pursuing genetic counseling and testing services will be referred to a patient navigator who will navigate participants to identified no cost or low cost services.
|
Total
n=57 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
47.24 years
STANDARD_DEVIATION 16.91 • n=5 Participants
|
49.50 years
STANDARD_DEVIATION 13.38 • n=7 Participants
|
48.35 years
STANDARD_DEVIATION 15.19 • n=5 Participants
|
|
Sex: Female, Male
Female
|
29 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
57 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black/African American
|
29 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
57 Participants
n=5 Participants
|
|
Genetic Counseling Knowledge
|
7.69 units on a scale
STANDARD_DEVIATION 1.75 • n=5 Participants
|
7.50 units on a scale
STANDARD_DEVIATION 1.45 • n=7 Participants
|
7.60 units on a scale
STANDARD_DEVIATION 1.60 • n=5 Participants
|
|
Self-Efficacy to Screen
|
14.38 units on a scale
STANDARD_DEVIATION 1.21 • n=5 Participants
|
14.29 units on a scale
STANDARD_DEVIATION 2.32 • n=7 Participants
|
14.33 units on a scale
STANDARD_DEVIATION 1.83 • n=5 Participants
|
PRIMARY outcome
Timeframe: 3 monthsOur primary outcome will be for participants to receive genetic testing and counseling.Investigators will be able to see if participant has scheduled a genetic testing appointment within the VCU Health appointment system.
Outcome measures
| Measure |
Fact Sheet Arm
n=29 Participants
Komen print materials about genetic counseling and testing will be given to women.
|
YouTube Video Arm
n=28 Participants
Participants in this arm will receive the culturally tailored video either via a Youtube link or a DVD.
YouTube Video Arm: Participants (n=25) will watch a 20 minute YouTube video that will describe the genetic counseling and testing process and risk/benefit information in a culturally relevant format. Participants will complete pre and post assessments. After the session, participants interested in pursuing genetic counseling and testing services will be referred to a patient navigator who will navigate participants to identified no cost or low cost services.
|
|---|---|---|
|
Rate of Genetic Counseling and Testing Uptake.
Counseling
|
18 Participants
|
15 Participants
|
|
Rate of Genetic Counseling and Testing Uptake.
Testing
|
7 Participants
|
12 Participants
|
SECONDARY outcome
Timeframe: Baseline was collected up to 48 hours from the start of the intervention and the follow-up was assessed within 48 hours post-intervention.The investigators measured general knowledge about hereditary breast and ovarian cancer. GCT knowledge was ascertained using a 13 item scale developed by Erblich et al.'s (2005). Example items included "have you ever heard about genetic counseling for BRCA 1 and 2?"" and have yes/no or true/false options. Scores across the 13 item Knowledge scale were summed with a range of ( 0-13) where higher values indicated higher knowledge.
Outcome measures
| Measure |
Fact Sheet Arm
n=26 Participants
Komen print materials about genetic counseling and testing will be given to women.
|
YouTube Video Arm
n=26 Participants
Participants in this arm will receive the culturally tailored video either via a Youtube link or a DVD.
YouTube Video Arm: Participants (n=25) will watch a 20 minute YouTube video that will describe the genetic counseling and testing process and risk/benefit information in a culturally relevant format. Participants will complete pre and post assessments. After the session, participants interested in pursuing genetic counseling and testing services will be referred to a patient navigator who will navigate participants to identified no cost or low cost services.
|
|---|---|---|
|
Knowledge Scale - Genetic Counseling and Testing Knowledge .
Follow-up
|
7.79 score on a scale
Standard Deviation 1.90
|
8.11 score on a scale
Standard Deviation 1.55
|
|
Knowledge Scale - Genetic Counseling and Testing Knowledge .
Baseline
|
7.69 score on a scale
Standard Deviation 1.75
|
7.50 score on a scale
Standard Deviation 1.45
|
SECONDARY outcome
Timeframe: Baseline was collected up to 48 hours from the start of the intervention and the follow-up was assessed within 48 hours post-intervention.The investigators measured participants self-efficacy in genetic counseling services.Self-efficacy was measured with 3 items on a 5-point likert-scale, with questions that was developed for this study. Example items include "how confident are you that you can cope with your risk of developing cancer?". Response options are on a 5-point likert scale ranging from not at all confident (1) and very confident (5). Scores across the 3- item scale were summed with a range of (3-15) where higher scores indicated higher self efficacy.
Outcome measures
| Measure |
Fact Sheet Arm
n=26 Participants
Komen print materials about genetic counseling and testing will be given to women.
|
YouTube Video Arm
n=26 Participants
Participants in this arm will receive the culturally tailored video either via a Youtube link or a DVD.
YouTube Video Arm: Participants (n=25) will watch a 20 minute YouTube video that will describe the genetic counseling and testing process and risk/benefit information in a culturally relevant format. Participants will complete pre and post assessments. After the session, participants interested in pursuing genetic counseling and testing services will be referred to a patient navigator who will navigate participants to identified no cost or low cost services.
|
|---|---|---|
|
Self-efficacy Scale
Follow-up
|
14.76 score on a scale
Standard Deviation 0.91
|
14.21 score on a scale
Standard Deviation 2.02
|
|
Self-efficacy Scale
Baseline
|
14.38 score on a scale
Standard Deviation 1.21
|
14.29 score on a scale
Standard Deviation 2.32
|
Adverse Events
Fact Sheet Arm
YouTube Video Arm
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place